MiR-501-3p/SPC24 axis affects cell proliferation, migration, invasion, apoptosis, and prognosis in renal cell carcinoma

被引:0
|
作者
Liang, Aidi [1 ,4 ,5 ]
Huang, Jiapeng [1 ,2 ,3 ]
He, Xinyi [1 ,2 ,3 ]
Tang, Xinru [1 ,2 ,3 ]
Xu, Xuncan [1 ,2 ,3 ]
Chen, Ming [1 ,2 ,3 ]
Meng, Lei [1 ,2 ,3 ]
Lin, Canbin [1 ,2 ,3 ]
机构
[1] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Urol, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Clin Res Acad Chinese Med, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Univ Chinese Med, Clin Med Sch 1, Guangzhou, Guangdong, Peoples R China
[4] Jinan Univ, Dept Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
[5] Guangdong Prov Key Lab Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
关键词
MiR-501-3p; SPC24; Renal cell carcinoma; ACHN; 786-O; MICRORNAS; CANCER; MIRNAS;
D O I
10.1590/1414-431X2024e13507
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has been confirmed that the expression of miR-501-3p is closely related to the behavior of several cancers. This study aimed to elucidate the effects of miR-501-3p/SPC24 axis on the behavior of renal cancer cells and to identify its prognostic value in renal cancer. First, the expression of miR-501-3p in the renal cell carcinoma (RCC) cell line was detected using real-time quantitative polymerase chain reaction (RT-qPCR). Second, cell function identification experiments were performed, including CCK-8, scratch, transwell invasion, and flow cytometry assays. Several databases were applied to explore the possible mechanism of miR-501-3p tumor suppressor effect in RCC. To explore the value of miR-501-3p/SPC24 axis in predicting renal cancer patient overall survival (OS), GEPIA (http://gepia.cancer-pku.cn/index.html) was used. Finally, western blot was performed to detect the expression level of SPC24 in renal cancer cells predicted by bioinformatics analysis. Dual-Luciferase Reporter Assay was used to verify if SPC24 is a target of mir-501-3p. MiR-501-3p was found to be down-regulated in cancer cells and tissues and to play a role in suppressing tumor cell proliferation, cell viability, cell migration, and cell invasion, while promoting apoptosis. We also found that high expression levels of SPC24 were associated with shorter OS time in patients diagnosed with renal cell carcinoma. In addition, the results of TCGA data analysis and western blot showed that the tumor suppressor effect of miR-501-3p may be achieved by targeting SPC24. The MiR-501-3p/SPC24 axis affects cell proliferation, migration, invasion, apoptosis, and prognosis in renal cell carcinoma.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Interferon Regulatory Factor 2 (IRF2) Inhibits the Invasion and Migration of Renal Clear Cell Carcinoma Cells by Downregulation of Spindle Pole Body Component 24 (SPC24)
    Lu, Bing
    Xu, Hongbo
    Ding, Meng
    Yan, Chunyin
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (10) : 1881 - 1890
  • [22] MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK
    Bao, Wei-Wei
    Shi, You-Ling
    Ma, Yan
    Qu, Xing-Hui
    Pang, Guang-Ming
    Yang, Lei
    HISTOLOGY AND HISTOPATHOLOGY, 2021, 36 (03) : 355 - 365
  • [23] miR-93-3p inhibition suppresses clear cell renal cell carcinoma proliferation, metastasis and invasion
    Wang, Lu
    Yang, Guang
    Zhu, Xiangwei
    Wang, Ziqi
    Wang, Hongzhi
    Bai, Yang
    Sun, Pengcheng
    Peng, Li
    Wei, Wei
    Chen, Guang
    Li, Guangbin
    Zamyatnin, Andrey A., Jr.
    Glybochko, Peter V.
    Xu, Wanhai
    ONCOTARGET, 2017, 8 (47) : 82824 - 82834
  • [24] lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis
    Zeng, Jiawei
    Li, Yuanmeng
    Wang, Yaodong
    Xie, Gang
    Feng, Qian
    Yang, Yuwei
    Feng, Jiafu
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020 (2020)
  • [25] miR-886-3p upregulation in clear cell renal cell carcinoma regulates cell migration, proliferation and apoptosis by targeting PITX1
    Yu, Zuhu
    Chen, Duqun
    Su, Zhengming
    Li, Yifan
    Yu, Wenshui
    Zhang, Qiang
    Yang, Lihua
    Li, Cailing
    Yang, Shangqi
    Ni, Liangchao
    Gui, Yaoting
    Mao, Zebin
    Lai, Yongqing
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 (05) : 1409 - 1416
  • [26] Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
    Quan, Jing
    Li, Yawen
    Pan, Xiang
    Lai, Yulin
    He, Tao
    Lin, Canbin
    Zhou, Liang
    Zhao, Liwen
    Sun, Shuolei
    Ding, Yu
    Tao, Lingzhi
    Hu, Yimin
    Wu, Xionghui
    Chen, Zebo
    Zhang, Fangting
    Ye, Jing
    Ni, Liangchao
    Lai, Yongqing
    ONCOLOGY LETTERS, 2018, 16 (02) : 2175 - 2184
  • [27] MicroRNA-222-3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma
    Zhao, Liwen
    Quan, Jing
    Li, Zuwei
    Pan, Xiang
    Wang, Jingyao
    Xu, Jinling
    Xu, Weijie
    Guan, Xin
    Li, Hang
    Yang, Shangqi
    Gui, Yaoting
    Chen, Yun
    Lai, Yongqing
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (01) : 525 - 534
  • [28] Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma
    Tao, Meiman
    Zhou, Yang
    Jin, Yichen
    Pu, Jinxian
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (02)
  • [29] MiR-224-5p Targeting OCLN Promotes the Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma Cells
    Liu, Yifei
    Nie, Honglin
    Zhang, Yubo
    Zhang, Na
    Han, Miaomiao
    Liu, Huancai
    Sun, Dongli
    Wu, Xiaotang
    Xiao, Xiaolong
    Cao, Xiaoning
    UROLOGIA INTERNATIONALIS, 2022, 106 (11) : 1185 - 1194
  • [30] RETRACTION: miR-660-5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma (Retraction of Vol 17, Pg 2051, 2018)
    He, Tao
    Chen, Peijie
    Jin, Lu
    Hu, Jia
    Li, Yifan
    Zhou, Liang
    Yang, Shangqi
    Mao, Xiangming
    Gui, Yaoting
    Chen, Yun
    Lai, Yongqing
    MOLECULAR MEDICINE REPORTS, 2024, 29 (05)